Actively planning for HU6’s late-stage development in MASH - - HU6 is potential best-in-class oral MASH therapy designed to address unmet needs in MASH through a unique energy expenditure approach - ...

ALT heads into a high-stakes 2026 as pemvidutide drives key phase III and mid-stage catalysts that could reshape its ...

GLP-1 medications that suppress appetite are allowing people to better manage diabetes and obesity. As weight-loss drug ...

The president’s executive order is intended to accelerate research into the compounds’ efficacy in treating mental health ...

Early results from a pilot study show the minimally invasive endoscopic intervention reduces the weight gain that occurs ...

The traditional media buying-selling model — built on manual negotiation and personal relationships — is being challenged by ...

D&D Pharmatech, a company specializing in the development of GLP-1 (glucagon-like peptide-1) class novel drugs, announced on April 22 that it has ...

Bottled at 116.4 proof, the 2026 release blends two mash bills and includes whiskies aged 7 to 8 years.

If you're looking for a ready-to-eat meal for a weeknight dinner, Costco's deli has brought out a new sous vide beef dinner ...

People of Note has a pleasant music-themed twist on turn-based gameplay. By Harold Goldberg In the pun-filled People of Note, ...

Oklahoma researchers found the hormone FGF21 targets the same brain region as GLP-1 drugs, but works by boosting metabolic ...

MLB player prop bets and odds for Elly De La Cruz on Wednesday, April 22, 2026, as the Cincinnati Reds take on the Tampa Bay ...